Latest Precigen News & Updates

See the latest news and media coverage for Precigen. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Precigen

Commercial-stage biopharmaceutical company

precigen.com
Headquarters
Germantown, United States
Founded year
2020
Company type
Public company
Number of employees
150–200

Last updated

Latest news about Precigen

In short: Precigen secured FDA approval for PAPZIMEOS, the first therapy for adult RRP, and reported a significant revenue increase during its 2026 launch.

Company announcements

Unlock all announcements with a

Media coverage

  • Benzinga

    Precigen Insider Trading Activity | NASDAQ:PGEN | Benzinga

    Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions...

  • The Globe and Mail

    Precigen sees Q1 revenue exceeding $18M, consensus $20.8M

    This substantial advancement constitutes a pivotal milestone for all stakeholders impacted by RRP." As a result of the interest in PAPZIMEOS, Sabzevari said the company...

  • Marketscreener

    (PGEN) Precigen Expects Q1 Revenue to Exceed $18M, vs. FactSet Est of $20.8M | MarketScreener

    The Company operates through two segments: Biopharmaceuticals and Exemplar. Biopharmaceuticals segment is primarily comprised of the Company's legal entities of Precigen and ActoBio, as well...

  • GuruFocus

    Precigen (PGEN) Sees Strong Demand for Papzimeos Immunotherapy

    Key Takeaways: Precigen's immunotherapy, Papzimeos, has seen a significant increase in adoption since its launch in August 2025. The assignment of J-code...

Unlock all articles with a

Never miss news about Precigen

Track Precigen and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Trending companies

Discover what's making headlines across other trending companies.